Treatment

BAY 3401016 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
BAY3401016; Biomarker Study Alport
This study is looking into a new medication called BAY 3401016 for adults with Alport Syndrome, a genetic kidney condition. It aims to see if this medicine can help slow down kidney damage by blocking a specific protein.
For: Alport Syndrome
United States · Argentina · Canada